Mechanism of Action

Mechanism of Action

Protein Kinase C Translocation and EBC-46: How Tigilanol Tiglate Drives Rapid Enzyme Redistribution

Tigilanol tiglate activates PKC isoforms by driving their translocation from cytosol to membrane. This redistribution triggers downstream signalling cascades central to EBC-46's biological effects.

Mechanism of Action

Integrin Signalling and EBC-46: How Tigilanol Tiglate May Disrupt Cell Adhesion in Tumour Microenvironments

An evidence-based look at how EBC-46 may interact with integrin signalling pathways, affecting cell adhesion and communication within tumour microenvironments.

Mechanism of Action

Mitochondrial Membrane Permeability and EBC-46: How Tigilanol Tiglate May Trigger Programmed Cell Death

Emerging research explores how EBC-46 may influence mitochondrial membrane integrity, potentially contributing to tumour cell apoptosis through intrinsic pathway activation.

Mechanism of Action

Vascular Disruption by EBC-46: How Tigilanol Tiglate Starves Tumours of Blood Supply

EBC-46 triggers rapid collapse of tumour vasculature through PKC-mediated endothelial disruption, cutting off nutrient supply and accelerating tumour necrosis within hours.

Mechanism of Action

Reactive Oxygen Species and EBC-46: How Oxidative Stress Contributes to Tumour Cell Death

PKC activation by EBC-46 triggers a burst of reactive oxygen species inside tumour cells. This oxidative stress cascade is a key mechanism in its anti-cancer effect.

EBC-46

Calcium Signalling and PKC Activation: How EBC-46 Triggers Rapid Intracellular Calcium Flux

PKC activation by EBC-46 initiates a rapid calcium signalling cascade that contributes to tumour cell death, immune recruitment, and vascular disruption at the injection site.

Mechanism of Action

Neutrophil Recruitment and Tumour Clearance: The Innate Immune Response to EBC-46

EBC-46 triggers rapid neutrophil infiltration at the injection site, creating a localised inflammatory response that accelerates tumour clearance within hours.

EBC-46

Diacylglycerol Mimicry: Why EBC-46 Binds PKC with Exceptional Selectivity

EBC-46 mimics the natural lipid messenger diacylglycerol to activate specific PKC isoforms — a molecular trick that explains its targeted anti-tumour effects.

EBC-46

PKC Isoforms and Mitochondrial Energy Metabolism: How EBC-46 Reaches Beyond the Tumour

EBC-46 targets PKC isoforms that regulate mitochondrial function and energy metabolism — a biological dimension that extends the compound's relevance well beyond oncology.

EBC-46

PKC Isoforms and Mitochondrial Energy Metabolism: EBC-46 Beyond the Tumour

The same PKC isoforms EBC-46 activates for anti-tumour effect also regulate mitochondrial membrane dynamics and cellular energy production — a scientifically rich area still awaiting systematic study.

EBC-46

PKC-Delta Activation: The Molecular Switch EBC-46 Flips

Tigilanol tiglate activates PKC-delta by mimicking the diacylglycerol second messenger, triggering simultaneous vascular disruption, immune cascade, and cancer-cell apoptosis within the tumour.

EBC-46

PKC Isoforms and Mitochondrial Energy Metabolism: How EBC-46 May Influence Cellular Bioenergetics

PKC-delta and PKC-epsilon isoforms play opposing roles in mitochondrial function — EBC-46's selective activation may reshape cellular energy production beyond tumour destruction.